Evidence map›Paper›PMID 41079659›Full record

ArticleChemical science2025

Monitoring structural change and drug release of responsive nanoparticles using polarity-sensitive fluorophores.

Yanting Gao, Peter W McDonald, Chris Ritchie, Georgina K Such

Abstract read
In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yanting GaoSchool of Chemistry, The University of Melbourne Parkville 3010 Victoria Australia gsuch@unimelb.edu.au.
Peter W McDonaldSchool of Chemistry, Monash University Clayton 3800 Victoria Australia chris.ritchie@monash.edu.ORCID https://orcid.org/0000-0003-2659-4778
Chris RitchieSchool of Chemistry, Monash University Clayton 3800 Victoria Australia chris.ritchie@monash.edu.ORCID https://orcid.org/0000-0002-1640-6406
Georgina K SuchSchool of Chemistry, The University of Melbourne Parkville 3010 Victoria Australia gsuch@unimelb.edu.au.ORCID https://orcid.org/0000-0002-2868-5799

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stimuli-responsive polymeric nanoparticles hold significant promise for enhancing the delivery of therapeutic agents, particularly peptides and other small biomolecules. To improve the efficiency of these drug delivery systems, accurate knowledge of their structural dynamics, disassembly process, and loading/release behavior is vital. Amongst a myriad of fluorescent probes utilized for this purpose, environmentally responsive fluorophores demonstrate distinctive advantages due to significant changes in fluorescence intensity, lifetime and/or emission wavelength with variation in their environment. In this work, we designed a series of novel multifunctional probe molecules, isoquinoline betaines (IQBs), with exquisite solvatofluorochromic properties. Through both a steady absorption signal in the visible wavelength range, and an environmentally dependent emission, these IQBs are a powerful tool for simultaneously tracking multiple key processes, including nanoparticle formation and disassembly, the loading and distribution of drug molecules, and the responsive release of drugs. This novel fluorescent probe was covalently conjugated to a pH-responsive nanoparticle and successfully probed the nanoparticle's internal structural rearrangement while also monitoring its drug-release activity of a model peptide in real-time. This IQB fluorescent probe system enhances our understanding of how nanoparticles interact with both their cargo and microenvironment and thus represents an important step forward in the development of more efficient drug delivery systems.

Identifiers

PMID41079659
PMCPMC12510257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.